The summary of responses will be published within three months, which could detail whether law changes would be introduced. It comes as the Government confirmed that an extension would be rolled out ...

Motorists are being alerted to changes in Vehicle Excise Duty (VED) coming into effect in April which will result in higher tax rates for many drivers. From April 2025 electric, zero and low ...

BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc ... the treatment of chronic cervical discogenic pain ("cCDP").

Cervical Discogenic Syndrome ... 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. We have also obtained FDA IND clearance to evaluate ...

We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. We have also obtained FDA IND clearance to evaluate BRTX-100 in the ...

BRTX-100 is the first and only stem cell product candidate cleared by the FDA for evaluation in the cervical degenerative disc ... addressing chronic cervical discogenic pain, which affects ...

BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc ... the treatment of chronic cervical discogenic pain (“cCDP”).

(MENAFN- GlobeNewsWire - Nasdaq) – BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting – – IND clearance ...

for the treatment of chronic cervical discogenic pain (“cCDP”). “Clearance of this IND for BRTX-100 represents a significant milestone and is a testament to the devotion of our talented scientific ...

We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. We have also obtained FDA IND clearance to evaluate BRTX-100 in the ...